Dissecting a population genome for targeted screening of disease mutations

Human Molecular Genetics

Volumn 10, Issue 26, 2001, Pages 2961-2972

  Pastinen, Tomi ^a,f   Perola, Markus ^a,b   Ignatius, Jaakko ^c,d   Sabatti, Chiara ^b   Tainola, Päivi ^a   Levander, Minna ^a   Syvänen, Ann Christine ^a,e   Peltonen, Leena ^a,b,d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e Department of Medical Sciences ^*  (Sweden)

^f Montreal Behavioral Medicine Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ANALYSIS; ARTICLE; BOTTLENECK POPULATION; CONTROLLED STUDY; DNA MICROARRAY; FINLAND; GENE CLUSTER; GENE MUTATION; GENE POOL; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HETEROZYGOTE; HISTORY; HUMAN; HUMAN GENOME; INFORMATION; MOLECULAR BIOLOGY; PHENOTYPE; PHYSICAL DISEASE; POPULATION GENETICS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SAMPLE; SCREENING;

EID: 0035894705     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.26.2961     Document Type: Article

References (67)

1. OMIM passes the 1000-disease-gene mark
2. DNA-based carrier screening in primary healthcare: Screening for aspartylglucosaminuria mutations in maternity health offices
3. Prenatal genetic carrier testing using triple disease screening
4. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and β-thalassemia disease carriers in high schools
5. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis
6. Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays
7. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population
8. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays
9. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
10. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
11. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study
12. Molecular genetics of the Finnish disease heritage
13. Mutation in blood coagulation factor V associated with resistance to activated protein C
14. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
15. Dual origins of Finns revealed by Y chromosome haplotype variation
16. The age of the mutations in the Finnish heritage: A genealogical and linkage disequilibrium study
17. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis
18. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8
19. A new gene., encoding an anion transporter, is mutated in sialic acid storage diseases
20. Mutations of the down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea
21. Three widespread founder mutations contribute to high incidence of X-linked juvenile retinoschisis in Finland
22. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome
23. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease
24. The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping
25. Linkage disequilibrium mapping in isolated populations: The example of Finland revisited
26. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness
27. Connexin 26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans
28. Cystic fibrosis in a low-incidence population: Two major mutations in Finland
29. Phenylketonuria in a low incidence population: Molecular characterisation of mutations in Finland
30. The incidence of Pku in Finland
31. Isolation of a novel gene underlying Batten disease, CLN3
32. Rapid diagnostic test for the major mutation underlying Batten disease
33. HLA-H and associated proteins in patients with hemochromatosis
34. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis
35. Characterization of single-nucleotide polymorphisms in coding regions of human genes
36. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype
37. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden)
38. Genetic distance between populations
39. Mutational analysis using oligonucleotide microarrays
40. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
41. Genome-wide mapping with biallelic markers in Arabidopsis thaliana
42. Minisequencing: A specific tool for DNA analysis and diagnostics on oligonucleotide arrays
43. Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays
44. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays
45. Universal DNA microarray method for multiplex detection of low abundance point mutations
46. Hereditary diseases in Finland; rare flora in rare soul
47. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis
48. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains
49. Detection of the Finnish-type congenital nephrotic syndrome by restriction fragment length polymorphism and dual-color oligonucleotide ligation assays
50. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG
51. The α 1-antitrypsin gene and its deficiency states
52. The prevalence of serum α 1-antitrypsin deficiency in Finland
53. Genetic background of hereditary hemochromatosis and DNA-diagnostics
54. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: A prospective cohort study in men in eastern Finland
55. Y chromosomal polymorphisms reveal founding lineages in the Finns and the Saami
56. Carrier screening for cystic fibrosis
57. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
58. Molecular diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by oligonucleotide ligation assay
59. Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland
60. Lessons from twin studies in Finland
61. Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: Application to aspartylglucosaminuria in Finland
62. Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia
63. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene
64. GENEPOP (version 1.2): Population genetics software for exact tests and ecumenicism
65. POPDIST, version 1.1.1: A program to calculate population genetic distance and identity measures